Cipla reported INR9.76 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Sep/2025 12.68 16.72 Oct/29
FY2027Q1 Jun/2026 9.76 11.76 16.06 Jul/22
FY2026Q4 Mar/2026 6.86 10.94 15.10 May/13
FY2026Q3 Dec/2025 11.20 14.92 19.43 Jan/23
FY2026Q1 Sep/2025 16.72 15.33 16.12 Oct/29




Eps Change Date
Arca Biopharma USD -0.58 0.04 Mar/2026
aTyr Pharma USD -0.06 0.59 Mar/2026
Bio Path USD -0.04 0.04 Mar/2026
Brainstorm Cell Therapeutics USD -0.19 0 Mar/2026
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Cara Therapeutics USD -0.72 0.14 Mar/2026
Cipla INR 9.76 2.9 Jun/2026
Dr.Reddys Laboratories INR 5.33 0.47 Jun/2026
Immunic USD -0.1 0.03 Dec/2025
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Nektar Therapeutics USD -1.78 0.43 Mar/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sun Pharmaceuticals INR 13.11 3.61 Jun/2026
TherapeuticsMD USD -0.09 0.02 Jun/2024
UPL INR 0.12 12.45 Jun/2026